Recent research has elucidated that TREM2 facilitates the microglial response to amyloid-beta through independent and spleen tyrosine kinase (SYK)-dependent mechanisms, as evidenced in the 5xFAD model of Alzheimer’s disease [84]. The gene discussed is TREM2; the disease is early-onset autosomal dominant Alzheimer disease.